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Abstract 
Objective: Many sections of the health care system are facing a major challenge making infectious disease problem‑
atic to treat; antimicrobial resistance (AMR). Identification and surveillance of the resistome have been highlighted 
as one of the strategies to overcome the problem. This study aimed to screen for AMR genes in an oral microbiota, a 
complex microbial system continuously exposed to antimicrobial agents commonly used in dental practice.
Materials and methods: As a significant part of the oral microbiome cannot be conventionally cultured, a functional 
metagenomic approach was chosen. The human oral metagenomic DNA was extracted from saliva samples col‑
lected from 50 healthy volunteers in Norway. The oral metagenomic library was then constructed by ligating partially 
digested oral metagenome into pSMART BAC vector and introducing into Escherichia coli. The library was screened 
against antimicrobials in dental practices. All resistant clones were selected and analyzed.
Results: Screening of the oral metagenomic library against different antimicrobials detected multiple clones with 
resistance against chlorhexidine, triclosan, erythromycin, tetracycline, and sodium hypochlorite. Bioinformatic analysis 
revealed both already known resistance genes, including msr, mef(A), tetAB(46), and fabK, and genes that were not 
previously described to confer resistance, including recA and accB conferring resistance to sodium hypochlorite and 
chlorhexidine, respectively.
Conclusion: Multiple clones conferring resistance to antimicrobials commonly used in dental practices were 
detected, containing known and novel resistant genes by functional‑based metagenomics. There is a need for more 
studies to increase our knowledge in the field.
Keywords: Antimicrobial resistance, Functional metagenomics, Oral metagenomic DNA, Dentistry, Chlorhexidine 
resistance, Sodium hypochlorite resistance
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Introduction
Antimicrobial agents have saved uncountable numbers of 
lives for decades since the discovery of Penicillin; how-
ever, with a worldwide increase of antimicrobial resist-
ance, infectious diseases currently have become more 
challenging to be treated. All uses of antimicrobials apply 
selective pressure to bacteria to evolve and develop anti-
microbial resistance [1–4]. Discovery of resistance genes 
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recovered from ancient samples showed that they were 
significantly similar to the modern resistance variants, 
suggesting antimicrobial resistance as an old natural 
phenomenon [5–7], but have recently become a prob-
lem possibly due to the selective pressures that acceler-
ated the spreading of resistance genes through horizontal 
gene transfer [8–10]. Identification and surveillance of 
the resistome are, therefore, essential in the battle against 
antimicrobial resistance, as they will improve our under-
standing of resistance genes in each setting which can be 
used to design effective strategies to limit the spreading 
between organisms and environments [11–13].
The human oral cavity is a complex microbial system 
[14, 15], housing a selection of bacteria with more than 
700 bacterial species [16–18]. It consists of several small 
ecosystems with unique environments such as kerati-
nized and non-keratinized mucosa, the tongue, saliva, 
tonsils, teeth, and subgingival pockets together mak-
ing up the oral microbiome [16, 19]. The species in the 
oral microbiome vary, from facultative aerobes to strict 
anaerobes. They are continuously exposed to antimicro-
bial agents from external products such as oral hygiene 
products as toothpaste, mouth rinse, agents used in den-
tal treatment and food, and is therefore likely to develop 
antimicrobial resistance. Relevant examples of anti-
microbials used in dental practices and dental hygiene 
products are chlorhexidine used in antimicrobial mouth 
rinses post-operative of surgical procedures [20], and 
for gingivitis and periodontitis patients who are unable 
to maintain adequate mechanical hygiene [21], sodium 
hypochlorite used as an irrigation agent during root 
canal treatment [22], sodium benzoate used in various 
toothpastes, cetyltrimethylammonium bromide (CTAB) 
found in throat lozenges and topical gels and conven-
tional antibiotics for patients with risk factors pre-oper-
ative of surgical procedures. Studies have shown that the 
oral microbiome contains resistance genes against vari-
ous antimicrobials agents such as β-lactams, tetracycline, 
tigecycline, amoxicillin, gentamicin, CTAB, erythromy-
cin and cetylpyridinium chloride [1, 23–28].
Of the more than 700 oral bacterial species, one-third 
of them are not cultured in the laboratory yet due to dif-
ficult and unknown proper conditions for growth [29, 
30], which has created challenges for characterizing the 
resistome in the oral microbiome. Functional metagen-
omics is a culture-independent approach, which relies on 
phenotypes of resistance genes, rather than the sequences 
of the resistance genes as in PCR and microarray [31–33]. 
It is, therefore, a method with the potential to discover 
completely novel resistance genes [34–37], without cul-
turing bacteria. It involves cloning of metagenomic DNA 
into a vector, introducing into a surrogate bacterial host, 
and screening for clones of phenotypes of interest, such 
as resistance traits. Several novel resistance genes were 
identified from the oral metagenome through a func-
tional metagenomic approach, such as tetracycline resist-
ance gene tet(37), tigecycline resistance gene tetAB(60) 
and quaternary ammonium compounds (QACs) resist-
ance gene galE [1, 23, 24].
In this study, we aimed to detect novel antimicro-
bial resistance genes from the human oral microbiome 
through a functional metagenomic approach. A human 
oral metagenomic library obtained from 50 healthy vol-
unteers in Norway was constructed and used to screen 
against antimicrobials that are commonly in contact 
with oral bacteria. We have identified multiple resistance 
clones against triclosan, CTAB, sodium hypochlorite, 
chlorhexidine, and erythromycin.
Methods
Study participants and collection of saliva samples
Ethical approval was obtained from Regional Commit-
tees for Medical and Health Research Ethics (Project 
number 2018/1373/REK nord). Saliva samples were col-
lected between October and November 2018 from 50 
healthy volunteers visiting the University Dental Clinic at 
UiT The Arctic University of Norway who were invited 
to participate in the study. All participants gave their 
written consent to participate in the study. The following 
criteria were used for participation: no history of antibi-
otic use in the last three months prior to saliva sampling, 
no history of regular medication, nor chronic diseases. 
All volunteers gave their written consent to participate 
in the study. The volunteers were asked not to drink, eat 
or brush their teeth within an hour before the collec-
tion. A paraffin gum was used to stimulate saliva secre-
tion during collection, and 2 mL of stimulated saliva was 
collected from each participant into a Saliva DNA Collec-
tion and Preservation Kit (Norgen Biotek Corp, Ontario, 
Canada). All samples were anonymized and stored at 
room temperature.
Extraction of oral metagenomic DNA and construction 
of the oral metagenomic library
Saliva metagenomic DNA was extracted from each sam-
ple by mixing 750  μl of each saliva in the preservation 
tube with 750 μl phosphate-buffered saline (PBS) buffer. 
This mixture was centrifuged for 10 min at 15,700×g. The 
supernatant was discarded and resuspended in 125  μl 
PBS and 25 μl MetaPolyzyme (Sigma-Aldrich, Norway). 
The samples were incubated at 35  °C for 4 h. The DNA 
samples were then extracted with QIAcube (Qiagen, 
Norway), following the protocol from QIAamp® DNA 
Mini QIAcube Kit.
For the construction of the oral metagenomic library, 
10 μl of extracted DNA was aliquoted from each of the 
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50 samples, making up 500 μl. The pooled metagenomic 
DNA was partially digested for 2, 3, and 4 min at 37  °C 
with HindIII restriction enzyme to serve us large DNA 
fragments. The digested product was run on an agarose 
gel electrophoresis, and DNA fragments with a size of 
more than 1000 bp were extracted by using QIAgen gel 
extraction kit (Qiagen). The pSMART BAC HindIII vec-
tor (7.6  kb) was fully digested and dephosphorylated 
by using HindIII restriction enzyme and calf intesti-
nal alkaline phosphatase (CIAP) enzyme (NEB, UK) at 
37  °C for 60 min. Afterwards, the partially digested oral 
metagenome was ligated into a pre-digested pSMART 
BAC vector by using Anza T4 DNA Ligase Master Mix 
(ThermoFisher, Norway) and incubated for 16 h at 4 °C. 
The ligation product was desalted in an agarose cone. The 
desalted ligation product (2 µl) was then mixed with 20 μl 
BAC-Optimized Replicator (BacRep) Escherichia coli 
Electrocompetent cells (Lucigen, USA), and transferred 
to a pre-chilled 0.1 cm electroporation cuvette (Bio-Rad, 
Norway). The mixture was electroporated with the fol-
lowing settings: 1.8 kV, 25 μF, 200 Ω (MicroPulser Elec-
troporator, Bio-Rad, Norway). A pre-warmed recovery 
medium (950 µl) (Lucigen, USA) was immediately added 
to the cells and incubated at 37 °C with shaking for 1 h, 
before plating 100 μl on Luria–Bertani (LB) Agar supple-
mented with 12.5 μg/ml chloramphenicol plate.
Determination of average insert size of the constructed 
oral metagenomic library
To determine the average insert size of the constructed 
oral metagenomics library, 10 random colonies from 
the LB Agar chloramphenicol control plate were sub-
cultured into 5 ml LB broth containing 12.5 μg/ml chlo-
ramphenicol and incubated at 37 °C with shaking at 200 
RPM for 18  h. The plasmids containing the insert from 
each clone were extracted by using QIAprep Spin Mini-
prep Kit (QIAgen, Norway), following the manufacturer’s 
protocol. After extraction, each plasmid was digested in 
10  μl reaction, containing 1  µl CutSmart buffer (10x), 
0.5  μl HindIII restriction enzyme, 1  μl plasmid, and 
7.5 μl distilled water. Each reaction was digested at 37 °C 
for 30 min. To visualize the inserts, each digested prod-
uct was run on agarose gel electrophoresis with 120  V 
for one hour. The average insert size of the constructed 
library was calculated based on the insert size of each 
sample, estimated from the gel.
Determination of minimum inhibitory concentration 
and screening of the oral metagenomic library
The minimum inhibitory concentration (MIC) of each 
antimicrobial was determined for E. coli BacRep contain-
ing pSMART BAC vector (with no insert), following the 
broth dilution method as described previously [38]. An 
overnight culture was set up by subculturing a single col-
ony into 5 ml LB broth containing 12.5 μg/ml chloram-
phenicol and incubated for 18 h at 37 °C with shaking at 
200 RPM. The overnight culture was diluted to the  OD600 
of 0.1. The MIC was determined in a 96-well microtiter 
plate by adding 10 μl of the diluted culture and 90 μl LB 
broth containing different concentrations of antimicro-
bial agents, shown in Table 1. The plates were incubated 
at 37  °C with shaking for 18–24  h, and the growth was 
determined by reading  OD600 before and after incubation 
with a microplate spectrophotometer. This was repeated 
three times for each antimicrobial.
For the screening of the oral metagenomic library for 
resistance clones, 100 μl of the electroporated E. coli car-
rying pSMART with oral metagenome insert were spread 
on LB agar supplemented with 12.5 μg/ml chlorampheni-
col and antimicrobial with the MIC concentration deter-
mined in the previous step, then incubated overnight at 
37  °C. All of the colonies grown on the screening plates 
of each antimicrobial were streaked onto a new antimi-
crobial containing plate, and also subcultured into 5  ml 
LB broth containing the antimicrobial to confirm the 
resistance.
Characterization of genes conferring antimicrobial 
resistance
The confirmed resistance clones were subcultured into 
5  ml LB broth, containing chloramphenicol and anti-
microbial of their resistance, and incubated at 37  °C 
for 18  h with shaking. The plasmids were extracted by 
using QIAprep Spin Miniprep Kit, digested with HindIII 
restriction enzyme, and visualized on an agarose gel to 
estimate the size of inserts.
All the inserts, except for the sodium hypochlorite-
clone, were amplified by setting up PCR reactions 
with Platinum SuperFi Green PCR Master Mix (Ther-
moFisher Scientific, Norway), which can amplify up to 
13 kb DNA, and SL1-SR4 primer pair (Lucigen, USA), 
which were the primers flanking the cloning site on the 
Table 1 Minimum inhibitory concentration (MIC) and the range 
of antimicrobials tested against E. coli BacRep containing empty 
pSMART BAC vector
Antimicrobial agents MIC Range
Sodium hypochlorite 0.025% 0.003125–0.1%
Chlorhexidine 1.0 μg/ml 0.313–10 μg/ml
Sodium benzoate 40 mg/ml 1.25–40 mg/ml
CTAB 4 μg/ml 1–32 μg/ml
Triclosan 30 μg/ml 0.16–80 μg/ml
Tetracycline 5 μg/ml 0.5–15 µg/ml
Erythromycin 175 μg/ml 75–200 μg/ml
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pSMART BAC vector. The 50-μl PCR reactions com-
posed of 2  µl SL1 forward primer (10  μM), 2  µl SR4 
reverse primer (10  μM), 25  µl 2 × Platinum SuperFi 
Green PCR Master Mix (Thermo Scientific, Nor-
way), 20  µl molecular grade water, and 1  μl plasmid. 
The PCR cycle was programmed, as suggested by the 
manufacturer’s protocol. The PCR products were puri-
fied by using QIAquick PCR Purification Kit (Qiagen, 
Norway), then sent for Sanger sequencing from both 
ends with SL-1 and SR-4 primers at Genewiz, Ger-
many. Additional primers were designed to extend the 
sequencing for samples that were not fully sequenced 
by the initial sequencing.
Sequencing data were aligned and manipulated by 
using BioEdit software version 7.2.0 (http:// www. mbio. 
ncsu. edu/ bioed it/ bioed it. html). The contigs of each 
sample were assembled by using CAP3 contig assembly 
program [39]. The assembled sequences were compared 
with sequences in the nucleotide and protein databases 
by using BlastN and BlastX from the National Centre 
for Biotechnology Information (NCBI) [40]. The nucleo-
tide sequences of all resistance clones were deposited 
in Genbank with the accession numbers MZ955857  to 
MZ955863.
Subcloning of putative genes conferring chlorhexidine 
and sodium hypochlorite resistance
The putative resistance genes were amplified from the 
plasmids extracted from chlorhexidine and sodium 
hypochlorite resistant clones by using primers listed in 
Additional file 1: Table S1. The 30-μl PCR reactions com-
posed of 15  µl 2 × BioMix Red (Bioline, United King-
dom), 2 μl of each primer (10 μM), 1 μl extracted plasmid 
and 10 μl molecular grade water. The PCR products were 
purified by using QIAquick PCR Purification Kit (Qiagen, 
Norway). All purified products, except recA PCR ampli-
cons, were digested with HindIII and ligated to a HindIII-
predigest pSMART BAC vector by using Anza T4 DNA 
Ligase Master Mix. The HindIII-ligated products were 
electroporated into BacRep E. coli Electrocompetent cells 
and grew on LB agar containing 12.5  μg/ml chloram-
phenicol. For the recA PCR amplicons, it was digested 
with EcoRI and ligated to an EcoRI-predigested pUC19 
vector instead as there was an internal HindIII restriction 
site in the recA gene. The pUC19-recA ligation product 
was introduced into Subcloning Efficiency™ DH5α Com-
petent Cells (Thermo Scientific, Norway) by heat-shock 
transformation and grew on LB agar containing 100 μg/
ml ampicillin. The listed of bacterial strains and plasmids 
from the subcloning of the putative resistance genes were 
shown in Additional file 2: Table S2.
Results
Screening of the constructed oral metagenomic library 
against antimicrobials used in dental practice
After the construction of the metagenomic library, the 
average insert size was calculated by determining the 
insert size from 10 random colonies, which showed the 
average insert size of the constructed library as 5500 bp 
(Additional file 3:  Fig. S1).
The MICs of E. coli BacRep carrying an empty 
pSMART BAC vector towards different antimicrobials 
were determined and listed in Table 1. The oral metagen-
omic library was then screened against each antimicro-
bial based on these MICs in which 7 different resistant 
clones were identified, including Chlorhexidine-1 (Chx-
1), Chlorhexidine-2 (Chx-2), Triclosan-1 (Tric-1), Tri-
closan-2 (Tric-2), Erythromycin-1 (Ery-1), Tetracycline-1 
(Tet-1) and Sodium hypochlorite-1 (NaOCl-1). HindIII 
plasmid digestion was performed to estimate the insert 
size of each resistant clone (Fig. 1). Sequencing and bio-
informatics analysis through BlastN and BlastX of each 
clone were performed and shown in Fig. 2 and Table 2.
Identification of genes conferring resistance 
in the identified resistant clones
Among 7 resistant clones identified from the screening, 4 
clones were shown to carry previously known resistance 
genes. For Ery-1, it contained msr and mef(A) macrolide 
resistance genes, that encode for a macrolide efflux pump 
[41, 42]. The tetracycline-resistant clone Tet-1 carried 
tetAB(46), an ABC-transporter which was isolated pre-
viously from the human oral cavity [24, 43]. It has been 
proved to transport tetracyclines over the cell membrane 
in both Gram-positive and Gram-negative bacteria, but 
as a single-drug efflux pump [43]. Both Tric-1 and Tric-2 
contained fabK (an isoform of fabI), encoding for an 
enzyme, enoyl-acyl carrier protein reductase II (ENR). 
ENR is involved in the fatty acid synthesis, and also the 
binding site for triclosan to inhibit the synthesis. Upregu-
lation of ENR resulted in a lower inhibitory effect from 
triclosan, as shown previously [1].
For chlorhexidine resistant clones (Chx-1 and Chx-2), 
bioinformatics analysis showed that they each contain 
only one complete open reading frame with the size of 
750 bp and 489 bp, respectively. Blast analysis of the ORF 
in Chx-1 did not show any match by blastN and blastP. 
A partial match was shown by blastX that it had a 236-
bp region that showed 51% similarity to a part of type IV 
secretion system DNA-binding domain-containing pro-
tein from Kocuria indica. The complete ORF in Chx-2 
was matched to accB gene, encoding acetyl-CoA carbox-
ylase biotin carboxyl carrier protein. As there were also 
another 2 incomplete ORFs in Chx-2, the accB gene of 
Chx-2 was amplified and subcloned into pSMART BAC 
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Fig. 1 HindIII digestion of plasmids extracted from resistant clones identified from the oral metagenomic library. pSMART BAC vector backbone 
was indicated with the green arrow. Lane M, HyperLadder™ 1 kb. U, undigested plasmid; D, digested plasmid. The digested product was run on a 
GelRed® precast gel
Fig. 2 Schematic representation of predicted ORFs found on insert DNA of each resistant clone. The open arrowed boxes represent ORFs, pointing 
in the probable direction of transcription. The known resistant genes and other genes are shown in green and blue, respectively. The dash boxes 
and arrow boxes represent the regions that are not found on the inserts, compared to the sequences in the database
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vector to confirm that it is the only gene responsible for 
the chlorhexidine resistance phenotype. The MIC of chlo-
rhexidine against E. coli BacRep::pSMART-Chx-1, E. coli 
BacRep::pSMART-Chx-2 and E. coli BacRep::pSMART-
accB were shown to increase two-fold (from 1.0 to 2.0 µg/
ml), compared to the wild-type E. coli BacRep::pSMART.
Bioinformatic analysis showed that the insert DNA of 
NaOCl-1 clone contained multiple genes, (as shown in 
Fig. 2 and Table 2) none of them was reported as a gene 
conferring sodium hypochlorite resistance. Four puta-
tive genes, encoding methyltransferase, diaminopimelate 
epimerase (DapF), hemin ABC transporter and RecA, 
were amplified and subcloned to determine the gene that 
conferred sodium hypochlorite resistance. The subclon-
ing results showed that only E. coli DH5α::pUC19-recA 
showed an increase in MIC against sodium hypochlorite 
from 0.040 to 0.050%, compared to the wild-type E. coli 
DH5α::pUC19.
The distribution of all detected resistance genes was 
determined by performing BlastN on the metagenomic 
sequencing data of each saliva oral metagenomic DNA. 
The results showed that 6 of 7 detected resistance genes 
could be found in all 50 subjects, and the last one (Chx-1) 
could be found in 4 out of 50 subjects (Additional file 4).
Discussion
Antimicrobial resistance is a major burden for the health-
care system worldwide. Several AMR genes have been 
discovered from the human oral microbiome previously. 
Some of them were found to be associated with mobile 
genetic elements, such as Tn916 family conjugative 
transposons [44, 45], that can facilitate that spreading 
to other oral bacteria, including pathogens. As the oral 
cavity is the entry point to both the respiratory and gas-
trointestinal tract, oral bacteria that contain these resist-
ance genes can therefore easily wander through the body 
via the bloodstream or by swallowing, and thereby have 
the potential to transfer their resistance genes to other 
microbiomes [25]. Therefore, it is important to screen 
and identify resistance genes in the oral microbiome so 
that we can design effective strategies and guidelines for 
antimicrobial uses to limit the spreading of these genes.
In our study, we used functional metagenomics to 
screen the oral metagenome for resistance genes against 
the antimicrobials used in dental practices, where 7 
resistance clones were identified. Four of them contained 
previously known AMR, which also could be found in the 
oral cavity, where one of them (fabI) was found by func-
tional metagenomic screening [1, 43, 46, 47]. The rest did 
not contain known resistance genes: two of them showed 
resistance to chlorhexidine, and another clone had 
resistance against sodium hypochlorite. This is the first 
time that functional metagenomic screening identified 
resistance genes for both antimicrobials from the oral 
metagenome.
Chlorhexidine is a widely used broad-spectrum antimi-
crobial in dentistry (e.g. endodontology, periodontology, 
oral surgery) [48]. It is normally combined with gluco-
nid or acetic acid to form water-soluble digluconate or 
diacetate salts [49]. The mode of action is dose-depend-
ent; bacteriostatic at low concentrations, bactericidal in 
higher, both through binding to negatively charged mem-
brane phospholipids, resulting in reduced membrane 
fluidity and osmoregulation [50, 51]. Therefore, in lower 
concentrations, it disrupts the membrane causing leakage 
of low-weight molecules, while, in higher concentrations, 
it causes cytolysis by forming precipitates and releasing 
intracellular components [49, 50].
For the Chx-2 clone, the gene responsible for resistance 
was accB, encoding for biotin carboxyl carrier protein 
(BCCP) which is a component of acetyl CoA carboxylase 
that catalyzes the first step in fatty acid and phospho-
lipid biosynthesis [52]. BCCP was previously reported to 
be one of the proteins that were upregulated as a conse-
quence of chlorhexidine exposure in a proteomic analysis 
of a resistant Pseudomonas aeruginosa [53]. In our study, 
we showed and confirmed that accB conferred chlorhex-
idine resistance by expressing a heterologous accB, recov-
ered from the oral cavity, in an E. coli surrogate host. 
Overexpressing accB in E. coli could increase the rate of 
phospholipid biosynthesis, which is the main component 
in the bacterial cell membrane, allowing the bacteria to 
become less sensitive against chlorhexidine which targets 
phospholipids in the cell membrane.
Sodium hypochlorite is an irrigation agent that is 
widely used in endodontic procedures, such as root canal 
fillings, by dentists. It is antimicrobial mainly in wet envi-
ronments as it ionizes to  Na+ and  OCl−. At pH levels 
between 4 and 7, its form is hypochlorous acid (HClO), 
while at pH > 9 it is  OCl−—both of them reactive oxidiz-
ing agents [54]. Teeth with pulp necrosis have a pH value 
between 6–7.4 before treatment, which means that HClO 
is the most important form of sodium hypochlorite for 
the treatments [55]. However, it is the tissue-dissolving 
property that may be considered the most important one 
for the procedures, where peptide bonds are destroyed, 
followed by dissolving proteins that can be irrigated away 
from the root canal [56].
The antimicrobial effect of sodium hypochlorite has 
been shown to be a complex process. As it is an oxi-
dative antimicrobial, it causes oxidative stress which 
damage both DNA and lipids [57, 58]. We found that 
recA, isolated from the oral metagenome in our study, 
could confer sodium hypochlorite resistance when in E. 
coli host. RecA plays an important role in homologous 
recombination and DNA repairs like SOS response that 
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is activated by DNA damage from various environmen-
tal factors and antibiotics. Previously, it was demon-
strated that mutations in recA and recB repair genes 
increased the sensitivity an E. coli strains to HClO 
[59, 60]. In our case, as the E. coli lab strains (DH5α 
and BacRep) were recA-deficient strains, introducing 
pSMART BAC and pUC19 plasmids containing recA 
would result in complementation of recA in these E. 
coli lab strains, which was shown to have higher MIC 
against NaOCl.
It is a common practice in functional genomic stud-
ies to use E. coli to test the metagenomic constructed 
libraries. In the current study, E. coli was utilised to 
express accB and recA genes. Although the two genes 
are housekeeping genes, it is advisable to assess the 
expression of these genes in oral bacteria given their 
heterogeneous nature.
The two newly recognized AMR genes were not asso-
ciated with mobile genetic elements, which implies 
that they are not able to be transferred or spread by 
themselves. However, it has been shown that selec-
tive pressure from uses of antimicrobials could drive 
these housekeeping genes to be associated with mobile 
genetic elements like fabI gene found in IS1272 com-
posite transposons [61], which give them the ability to 
be spread. Exposing bacteria to compounds like sodium 
hypochlorite could also lead to the spread of antibiotic 
resistance genes between bacteria, as it can induce an 
SOS-response in bacteria which promotes the spread 
of mobile genetic elements like integrative conjugative 
elements (SXT) that can facilitate an intercellular trans-
position [62].
Chlorhexidine is most used as a mouth rinse the days 
after a third mandibular molar surgery, to treat pericor-
onitis as well as it might be considered as an additional 
treatment for periodontitis patients with impaired access 
to adequate mechanical hygiene [63–65]. It is known 
that mouth rinses containing chlorhexidine reduce the 
amount of plaque in the oral cavity [21, 48], which is 
important as we know that the oral microbiota can play 
an important role in respiratory infections [66–68]. There 
is also a known relationship between the presence of oral 
bacteria, specifically viridans group streptococci, and 
infectious endocarditis (IE) [69–71]. A hot topic of dis-
cussion is the use of antibiotic prophylaxis in dental pro-
cedures that increase the risk of infectious endocarditis. 
In England, it has been observed that with more restric-
tive use of antibiotic prophylaxis, the incidence of IE has 
also increased [72]. Therefore, it is crucial for the health 
system to design a proper and well-balanced dental anti-
microbial stewardship that can minimize the spread of 
AMR genes but still effectively prevent infection in dental 
treatments at the same time.
Conclusion
In conclusion, multiple clones conferring resistance to 
antimicrobials commonly used in dental practices were 
detected in the studied population, proved to contain 
known and novel AMR genes when screened by func-
tional-based metagenomics. This emphasizes the impor-
tance of reducing all use of antimicrobials, as this will 
reduce the selective pressure that could drive the spread 
of AMR genes even from commensal oral bacteria to 
pathogens. There is a need for more studies in this field to 
increase our knowledge regarding the AMR crisis.
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